Business Description
Mezzion Pharma Co
ISIN : KR7140410002
Compare
Compare
Traded in other countries / regions
140410.Korea IPO Date
2012-01-20Description
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 116.59 | |||||
| Equity-to-Asset | 0.67 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.05 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 20.44 | |||||
| Beneish M-Score | -2.13 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 0.7 | |||||
| 3-Year EBITDA Growth Rate | 4.1 | |||||
| 3-Year EPS without NRI Growth Rate | 5.5 | |||||
| 3-Year FCF Growth Rate | -11.2 | |||||
| 3-Year Book Growth Rate | -0.8 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18 | |||||
| 9-Day RSI | 29.79 | |||||
| 14-Day RSI | 37.13 | |||||
| 6-1 Month Momentum % | 11.99 | |||||
| 12-1 Month Momentum % | 128.71 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.51 | |||||
| Quick Ratio | 2.31 | |||||
| Cash Ratio | 1.97 | |||||
| Days Inventory | 99.99 | |||||
| Days Sales Outstanding | 33.83 | |||||
| Days Payable | 66.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.5 | |||||
| Shareholder Yield % | 0.12 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 12.25 | |||||
| Operating Margin % | -45.68 | |||||
| Net Margin % | -40.13 | |||||
| FCF Margin % | -72.13 | |||||
| ROE % | -26.48 | |||||
| ROA % | -16.9 | |||||
| ROIC % | -47.22 | |||||
| ROC (Joel Greenblatt) % | -310.62 | |||||
| ROCE % | -24.52 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 32.45 | |||||
| PB Ratio | 17.58 | |||||
| Price-to-Tangible-Book | 22.27 | |||||
| EV-to-EBIT | -84.03 | |||||
| EV-to-EBITDA | -96.26 | |||||
| EV-to-Revenue | 32.23 | |||||
| EV-to-FCF | -46.29 | |||||
| Price-to-Median-PS-Value | 0.93 | |||||
| Price-to-Net-Current-Asset-Value | 24.8 | |||||
| Price-to-Net-Cash | 39.21 | |||||
| Earnings Yield (Greenblatt) % | -1.19 | |||||
| FCF Yield % | -2.12 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mezzion Pharma Co Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 31,720.933 | ||
| EPS (TTM) (â‚©) | -454 | ||
| Beta | 0.8 | ||
| Volatility % | 67.22 | ||
| 14-Day RSI | 37.13 | ||
| 14-Day ATR (â‚©) | 1731.446976 | ||
| 20-Day SMA (â‚©) | 39562.5 | ||
| 12-1 Month Momentum % | 128.71 | ||
| 52-Week Range (â‚©) | 17900 - 54100 | ||
| Shares Outstanding (Mil) | 29.59 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mezzion Pharma Co Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mezzion Pharma Co Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Mezzion Pharma Co Frequently Asked Questions
What is Mezzion Pharma Co(XKRX:140410)'s stock price today?
The current price of XKRX:140410 is â‚©36500.00. The 52 week high of XKRX:140410 is â‚©54100.00 and 52 week low is â‚©17900.00.
When is next earnings date of Mezzion Pharma Co(XKRX:140410)?
The next earnings date of Mezzion Pharma Co(XKRX:140410) is .
Does Mezzion Pharma Co(XKRX:140410) pay dividends? If so, how much?
Mezzion Pharma Co(XKRX:140410) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers